PL337606A1 - Derivatives of erythromycin 9-oxime - Google Patents

Derivatives of erythromycin 9-oxime

Info

Publication number
PL337606A1
PL337606A1 PL98337606A PL33760698A PL337606A1 PL 337606 A1 PL337606 A1 PL 337606A1 PL 98337606 A PL98337606 A PL 98337606A PL 33760698 A PL33760698 A PL 33760698A PL 337606 A1 PL337606 A1 PL 337606A1
Authority
PL
Poland
Prior art keywords
erythromycin
oxime
derivatives
Prior art date
Application number
PL98337606A
Inventor
Young-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL337606A1 publication Critical patent/PL337606A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL98337606A 1997-06-11 1998-05-15 Derivatives of erythromycin 9-oxime PL337606A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
PL337606A1 true PL337606A1 (en) 2000-08-28

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337606A PL337606A1 (en) 1997-06-11 1998-05-15 Derivatives of erythromycin 9-oxime

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
ATE298761T1 (en) * 1998-09-22 2005-07-15 Pfizer Prod Inc CARBAMAT AND CARBAZATE KETOLID ANTIBIOTICS
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
BR0010938A (en) 1999-05-24 2002-03-19 Pfizer Prod Inc 13-Methyl erythromycin derivatives
WO2000075156A1 (en) * 1999-06-07 2000-12-14 Abbott Laboratories 6-o-carbamate ketolide derivatives
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
JP5383037B2 (en) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド Macrocyclic compounds and methods of making and using them
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
ES2565083T3 (en) 2008-10-24 2016-03-31 Cempra Pharmaceuticals, Inc. Biodefenses using macrolides containing triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (en) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedures for the treatment of malaria, tuberculosis and MAC diseases
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
BR112012029586A2 (en) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processes for preparing macrolides and ketolides and intermediates thereof
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
JP6426696B2 (en) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ,インコーポレイテッド Methods and formulations for the treatment of respiratory diseases
CA2907085A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
AP9801253A0 (en) 1999-12-04
HN1998000073A (en) 1999-01-08
IS5251A (en) 1999-11-16
HRP980316A2 (en) 1999-04-30
CA2293335A1 (en) 1998-12-17
TR199902995T2 (en) 2000-02-21
HUP0002252A2 (en) 2000-12-28
GT199800074A (en) 1999-11-27
WO1998056800A1 (en) 1998-12-17
PA8451801A1 (en) 2000-05-24
EP0988308A1 (en) 2000-03-29
BG103947A (en) 2000-07-31
MA26505A1 (en) 2004-12-20
CZ9904388A3 (en) 2002-10-16
NO996108D0 (en) 1999-12-10
TNSN98083A1 (en) 2005-03-15
KR20010013660A (en) 2001-02-26
PE79899A1 (en) 1999-08-25
HUP0002252A3 (en) 2002-01-28
CN1259135A (en) 2000-07-05
NO996108L (en) 2000-02-10
TW448174B (en) 2001-08-01
OA11225A (en) 2003-07-17
CO4940506A1 (en) 2000-07-24
AR012244A1 (en) 2000-09-27
IL132767A0 (en) 2001-03-19
EA199901016A1 (en) 2000-06-26
JP2000513026A (en) 2000-10-03
ZA985018B (en) 1999-12-10
AU7226798A (en) 1998-12-30
BR9810021A (en) 2000-09-19
ID24529A (en) 2000-07-20

Similar Documents

Publication Publication Date Title
PL337606A1 (en) Derivatives of erythromycin 9-oxime
HUP0001518A3 (en) Tricyclic erythromycin derivatives
PL341647A1 (en) Novel derivatives of erythromycin
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
PL348333A1 (en) Macrolides
IL137024A0 (en) Novel macrolides
HUP0104192A3 (en) Novel macrolide antibiotics
PL340290A1 (en) 2-halogeno-6-0-substituted derivatives of ketolide
PL339137A1 (en) 6,9-bridged derivatives of erythromycin
PL340253A1 (en) 6,11-bridged derivatives of erythromycin
PL324346A1 (en) Macrolides
ZA985655B (en) Crystalline macrolides
IL145256A0 (en) Erythromycin derivatives
AU8925398A (en) 3-descladinose 6-o-substituded erythromycin derivatives
AU6932098A (en) Erythromycin derivatives
IL115312A0 (en) Antibiotic macrolides
AU1504899A (en) Erythromycin derivatives
PL337066A1 (en) Polycyclic derivatives of erythromycin
GB9700702D0 (en) Erythromycin derivatives
ZA951845B (en) Acid-stabile erythromycin derivatives
HK1031384A (en) 3-descladinose 6-o-substituted erythromycin derivatives
ZA989845B (en) 2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (en) 2-halo-6-o-substituted ketolide derivatives
AU3634397A (en) Erythromycin derivatives
PL319678A1 (en) Method of biosynthesising erythromycin c